B-cell lymphoma of the heart: A rare diagnosis

Abstract

We present a case of a primary cardiac lymphoma in a 60-year-old woman. The clinical presentation was non-specific and the diagnosis was suggested by its appearance on multidetector computed tomography. The final diagnosis was achieved by histopathological study and was corroborated by a decrease in tumor volume after targeted chemotherapy. A brief review of the appearance of primary cardiac lymphomas in imaging studies is presented.

A rare primary pericardial DLBCL masquerading as an unexplained malignant pleural effusion in an elderly woman: A case report

“…Malignant effusion and supportive care remained significant in multivariate analyses. The ancillary method described was used to confirm the morphological presence of lymphomatous effusions in some cases [ 2 , 3 , [7] , [8] , [9] , [10] , 12 , 17 ].…”

“…Diffuse large B-cell lymphoma (DLBCL) is a common variant of non-Hodgkin lymphoma (NHL), accounting for approximately 40% of all lymphomas [ [1] , [2] , [3] , [4] , [5] , [6] ]. Primary cardiac and pericardial lymphoma involvement is an extremely rare NHL subset, accounting for 0.5% of cardiac involvement and 1% of extranodal NHL [ 6 ].…”

“…Pericardial involvement with secondary pleural effusion is extremely rare [ 7 ]. Pericardial effusion is the most common presentation [ 2 , 3 , 5 , 6 , [8] , [9] , [10] , [11] , [12] ]. Pericardial lymphoma's clinical presentation is nonspecific and depends on tumour size and location.…”

A rare case of primary cardiac lymphoma

“…Primary cardiac lymphoma often arises from the right side of the heart, therefore infiltrating the RA or RV 4. In immunocompetent hosts, primary cardiac lymphoma is normally of a B-cell non-Hodgkin's type.…”

Linfoma Primário do Pericárdio: Uma Entidade Rara

“…O diagnóstico histológico foi de linfoma primário grandes células B do pericárdio, entidade rara com maior prevalência em doentes imunodeprimidos e na faixa etária 60 anos. [1][2][3][4] A clínica é fruste e o diagnóstico é imagiológico e histológico. Tem mau prognóstico, sendo recomendada quimioterapia paliativa na maioria dos casos.…”